Street Calls of the Week
IonQ, Inc. (NYSE:IONQ) announced Thursday that it has filed a prospectus supplement with the Securities and Exchange Commission for the resale of 12,377,433 shares of its common stock by certain selling stockholders. The shares have a par value of $0.0001 per share. The company, currently valued at $12.8 billion, has seen remarkable market performance with a 490% return over the past year, according to InvestingPro data.
According to the company’s statement in the SEC filing, the prospectus supplement relates to the registration statement on Form S-3ASR that was initially filed on February 26, 2025. The filing covers only the resale of shares by existing stockholders and does not involve the issuance of new shares by the company.
The legal opinion related to the shares covered by the prospectus supplement was provided by Wilson Sonsini Goodrich & Rosati, Professional Corporation, and is included as an exhibit to the filing.
IonQ’s common stock and warrants are listed on the New York Stock Exchange under the symbols NYSE:IONQ and NYSE:IONQ WS, respectively.
This information is based on a press release statement included in the company’s recent SEC filing.
In other recent news, IonQ, Inc. is experiencing significant developments across various fronts. The company has been initiated with a Buy rating by B.Riley, with analyst Craig Ellis setting a price target of $61.00, highlighting IonQ’s leadership in revenue growth within the quantum computing sector. B.Riley projects that IonQ could continue its impressive growth trajectory, potentially achieving $1.0 billion in sales by 2030. Additionally, IonQ has expanded its intellectual property portfolio to over 1,000 patents and patent applications, focusing on innovations in trapped-ion quantum computing technology. This includes advancements in secure long-distance quantum networking and quantum memory devices. Furthermore, the board of IonQ has approved equity awards and salary adjustments for its senior executives, with CEO Niccolo de Masi receiving a significant restricted stock unit grant. The company is also strengthening its leadership team with the appointment of four new vice presidents across key divisions. Lastly, Morgan Stanley has raised its price target for IonQ to $32.00 while maintaining an Equalweight rating, reflecting a revised valuation range within the quantum peer group.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.